Results 151 to 160 of about 543,294 (294)

AI‐Driven Acceleration of Fluorescence Probe Discovery

Advanced Science, EarlyView.
We present PROBY, an AI model trained on large‐scale datasets to predict key photophysical properties and accelerate the discovery of target‐specific fluorescent probes. By screening a target‐annotated library, PROBY identifies candidate probes for diverse targets and could guide probe optimization, enabling a range of in vitro and in vivo imaging ...
Xuefeng Jiang, Yanbo Li, Xue Tian, Sen Yang, Ruina Luo, Cenxing Zhou, Yuxuan Liu, Jingying Hu, Sen Feng, Lu Gan, Chongzhao Ran, Kun‐Hsing Yu, Junhan Zhao, Xiao Han, Xuan Zhai, Yuntao Jia, Jiapei Dai, Xiyue Wang, Biyue Zhu   +18 more
wiley   +1 more source

Informed Consent in Radiation Oncology: A Nationwide Survey of Institutions in Korea. [PDF]

J Korean Med Sci
Kang JK, Kim K, Park HJ, Jang WI, Kim BH, Kim KS, Informatics Committee and Clinical Practice Guideline Committee of the Korean Society for Radiation Oncology.   +6 more
europepmc   +1 more source

Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis [PDF]

, 2018
Badiyan, Shahed, Gay, Hiram A, Markovina, Stephanie, Meeks, Marshall W, Michalski, Jeff, Paradis, Alethea, Sandhu, Gurdarshan, Vetter, Joel   +7 more
core   +2 more sources

An Engineered Solidified Peptide Hemocyte Sponge as Nanomotor Storage to Combat Bacterial Colitis

Advanced Science, EarlyView.
Peptides immobilized via nickel coordination can stabilize the framework structure. Following coating with red blood cell membranes, these constructs are capable of continuously sequestering endotoxins and mitigating colonic pathogenic damage by alleviating bacterial‐induced ferroptosis.
Yuxin Fang, Jianming Yan, Tongxin Yu, Zichuan An, Kaikai Lv, Chenyu Xue, Hongyang Yu, Na Dong, Anshan Shan   +8 more
wiley   +1 more source

Advances in the Prevention and Treatment of Radiation Skin Injury: Mechanisms, Pharmacological Interventions, and Applications of Novel Dressings

International Journal of Nanomedicine
Yi Liu,1,2,* Jiahuan Xu,1,3,* Shirui Yang,1,4,* Shaoran Song,1 Shuhong Zhao,1 Yunzhi Dang1,3– 5 1Department of Radiation Oncology, Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi, 710086, People’s Republic of China ...
Liu Y, Xu J, Yang S, Song S, Zhao S, Dang Y   +5 more
doaj  

Research with cancer registry data in radiation oncology-current possibilities and perspectives : A narrative review. [PDF]

Strahlenther Onkol
Müller JA, Bedir A, Katalinic A, Oesterling F, Graw A, Kluttig A, Corradini S, Vordermark D, Medenwald D.   +8 more
europepmc   +1 more source

Stimuli‐Responsive Supramolecular Biomaterials for Cancer Theranostics

Advanced Science, EarlyView.
The ultimate goal of cancer theranostics is to get imaging agents and therapeutic cargo to tumor sites when and where they are required. “Smart” systems should be developed. This review discusses the characteristics of physiological stimuli, types and action modes of external stimuli, construction approaches and working principles, as well as ...
Wenting Hu, Binglin Ye, Guocan Yu, Feihe Huang, Zhengwei Mao   +4 more
wiley   +1 more source

Telehealth in Radiation Oncology: Time to Refine, Not Just Expand. [PDF]

Cureus
Luh JY.
europepmc   +1 more source

Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal/prostate spacer: Secondary analysis of a phase 3 trial [PDF]

, 2018
Bosch, Walter, Chundury, Anupama, et al,, Fischer-Valuck, Benjamin W, Gay, Hiram A, Michalski, Jeff   +5 more
core   +1 more source

DNMT2‐m5C‐ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation‐Mediated Notch Pathway

Advanced Science, EarlyView.
Lenvatinib resistance poses a major challenge in advanced hepatocellular carcinoma (HCC). This study reveals that DNMT2 upregulation is a key driver, which stabilizes ACLY mRNA via m5C modification and activates the Notch signaling pathway. Crucially, combining ACLY inhibitors with lenvatinib overcomes resistance and suppresses tumors, offering a ...
Shiguang Yang, Jie Li, Shengwei Mao, Xuhui Zhao, Douwaner Liu, Jiafeng Chen, Jialu Fu, Yichao Bu, Xiaoling Wu, Shaoqing Liu, Qifeng Yu, Qiongzhu Dong, Zheng Tang, Yuan Fang, Yinghong Shi   +14 more
wiley   +1 more source